Table 5.
Nanocarrier | Advantages | Disadvantages | Reference |
---|---|---|---|
Liposome | Uses for a wide variety of drugs and capable of increasing drug load while reducing unwanted drug activity. | Toxicity is caused by cationic lipids. The mononuclear phagocyte system degrades the nanocarriers quickly. |
[56] |
Dendrimer | It has higher loading capacity due to a variety of multifunctional surface groups and intracellular cavities, as well as it has high bioavailability. | Rapid clearance, organ accumulation, synthesis variability | [56] |
Micelles | Reduction of toxicity and other adverse effects. | Use only for lipophilic drugs, low drug loading capacity | [56,57] |
Carbon nanotube | To deliver chemotherapeutic and imaging agents, it must be capable of penetrating and localize at the cellular level. | Potential material toxicity | [57] |
Polymeric nanoparticles | These are biocompatible, biodegradable, nontoxic, have a longer blood circulation time, less drug change, are less reactive to enzymatic degradation, and site-targeted administration. | Degradation of the carrier | [58] |
Solid lipid nanoparticles (SLNs) | Due to its organic nature, it has a high solubility and bioavailability. | ||
The kinetics of medication release can be better controlled. | Low drug loading capacities Possibly containing other colloidal structures and complex physical state |
[59] | |
Nanostructured lipid carrier (NLCs) | It is second generation SLNs having high drug loading and entrapment potential. | ||
Long-term stability, prevent particles from coalescing, low toxicity, biodegradation, drug protection. | Gelation of lipid dispersion Polymorphic transition |
[59] | |
Biocompatible to a high degree. | |||
Organic solvents may be avoided since the procedures are water-based. | |||
Simple to scale-up and sterilize, and they are less costly than other materials. | |||
Carriers based on polymers or surfactants. | |||
Improve drug release control and/or target. | |||
When compared to other NLCs, NLCs provide excellent and greater medication content. | |||
NLCs may transport both lipophilic and hydrophilic molecules. Biodegradability of the majority of lipids. |